Abstract
Fungal infections, especially invasive fungal disease(IFD) is one of the major causes which incresae the mortality after allogeneic hematopoietic stem cell transplantation(allo-HSCT). Several researches have confirmed that optimal antifungal prophylaxis can reduce the risks of proven or probable invasive fungal infections in allo-HSCT patients. However, the epidemiology characteristic of pathogen, as well as the immunity reconstruction in allo-HSCT patients should be taken into account when making decisions on the choice of prophylactic antifungal agents. This article reviews literatures on advances in antifungal prophylaxis after allo-HSCT. Key words: Hematopoietic stem cell transplantaion; Mycoses; Antifungal agents
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Blood Transfusion and Hematology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
